According to the Clinical Trial Directive which Adverse Events require single case reporting to the Regulatory Authority
- All SAR (Serious Adverse Reactions)
- All SUSARs (Suspected Unexpected Serious Adverse Reactions)
- All ARs (Adverse Reactions)
- All SAEs (Serious Adverse Events)